Quinze-Vingts National Eye Hospital, UPMC Univ Paris 06-Sorbonne Universities, Paris, France.
Quinze-Vingts National Eye Hospital, UPMC Univ Paris 06-Sorbonne Universities, Paris, France.
Ophthalmology. 2016 Jul;123(7):1428-34. doi: 10.1016/j.ophtha.2016.03.034. Epub 2016 Apr 26.
To analyze the cumulated incidence of glaucoma after penetrating keratoplasty (PK), anterior lamellar keratoplasty (ALK), and endothelial keratoplasty (EK).
Cohort study. Data were recorded prospectively and analyzed retrospectively.
A total of 1657 consecutive eyes of 1657 patients undergoing corneal transplantation between 1992 and 2013.
Penetrating keratoplasty (date range, 1992-2013), ALK (date range, 2002-2013), and Descemet's stripping automated EK (date range, 2006-2013).
Postoperative intraocular pressure (IOP), glaucoma treatments, and glaucoma-related loss of vision (loss of central visual function resulting in absence of light perception or light perception limited to the temporal visual field). Cox proportional hazard regression model was used to analyze risk factors for glaucoma after keratoplasty.
The 10-year cumulated incidence of elevated IOP and elevated IOP requiring treatment was 46.5% and 38.7%, respectively. In multivariate analysis, 4 variables were significantly associated with a higher incidence of elevated IOP requiring treatment after keratoplasty: preoperative glaucoma or IOP >20 mmHg (adjusted hazard ratio [HR], 1.56; P < 0.001), penetrating keratoplasty (PK) (adjusted HR, 1.12 vs. ALK and 1.10 vs. EK; P < 0.001), postoperative lens status (adjusted HR vs. phakic eyes: 1.15 for posterior chamber intraocular lens, 1.43 for anterior chamber intraocular lens [IOL], 2.83 for aphakic eyes; P < 0.001), and IOL exchange or removal during surgery (adjusted HR, 1.48; P < 0.001). Recipient age, preoperative diagnosis, filtering surgery before keratoplasty, vitrectomy associated with keratoplasty, and filtering surgery associated with keratoplasty were significantly associated with a higher incidence of elevated IOP requiring treatment after keratoplasty in univariate analysis but not in multivariate analysis. The 10-year probability of loss of vision related to glaucoma was 1.0% after EK, 2.1% after ALK, and 3.6% after PK (P = 0.036).
The incidence of elevation of IOP after keratoplasty and development of glaucoma are significantly decreased with ALK and EK compared with PK. We believe this is due to diminished surgery-induced damage to the anterior chamber angle and trabecular meshwork, and reduced postoperative use of steroids.
分析穿透性角膜移植术(PK)、前板层角膜移植术(ALK)和内皮角膜移植术(EK)后青光眼的累积发生率。
队列研究。数据前瞻性记录并回顾性分析。
1992 年至 2013 年间共 1657 例 1657 只眼接受角膜移植。
穿透性角膜移植术(日期范围:1992-2013 年)、ALK(日期范围:2002-2013 年)和 Descemet 膜撕除自动化 EK(日期范围:2006-2013 年)。
术后眼压(IOP)、青光眼治疗及青光眼相关视力丧失(中央视觉功能丧失导致光感缺失或光感仅限于颞侧视野)。Cox 比例风险回归模型分析角膜移植术后青光眼的危险因素。
10 年累积IOP 升高和需要治疗的IOP 升高发生率分别为 46.5%和 38.7%。多变量分析中,4 个变量与角膜移植术后需要治疗的 IOP 升高发生率显著相关:术前青光眼或 IOP>20mmHg(校正危险比[HR],1.56;P<0.001)、穿透性角膜移植术(PK)(校正 HR,1.12 比 ALK 和 1.10 比 EK;P<0.001)、术后晶状体状态(与透明晶状体相比:后房人工晶状体为 1.15,前房人工晶状体[IOL]为 1.43,无晶状体眼为 2.83;P<0.001)和术中 IOL 置换或取出(校正 HR,1.48;P<0.001)。在单变量分析中,受者年龄、术前诊断、角膜移植术前滤过手术、伴角膜移植的玻璃体切除术以及伴角膜移植的滤过手术与角膜移植术后 IOP 升高需要治疗的发生率显著相关,但在多变量分析中则无相关性。EK 后 10 年青光眼相关视力丧失的概率为 1.0%,ALK 后为 2.1%,PK 后为 3.6%(P=0.036)。
与 PK 相比,ALK 和 EK 显著降低了角膜移植术后眼压升高和青光眼的发生。我们认为这是由于前房角和小梁网手术损伤减少,以及术后类固醇的使用减少。